EUVIMEDEUVIMED entdecken
Open Access

CoCoRV-nf: a powerful and cost-effective tool for rare variant analysis leveraging external biobank sequence data identified new candidate predisposition genes in amyotrophic lateral sclerosis and neuroblastoma

Saima Sultana Tithi, Johnathan Cooper-Knock, Michael Benatar iD, Joanne Wuu, J Paul Taylor, Gang Wu iD, Wenan Chen iD

Human Molecular Genetics · 10.08.2026 · 35 (17)

DOI: 10.1093/hmg/ddag076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 10.08.2026. Verfasst von Saima Sultana Tithi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell & Molecular Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Amyotrophic Lateral Sclerosis, Neuroblastoma, Software. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although sequencing costs have steadily decreased with advances in technology, they remain high for large scale studies. The design of traditional individual-disease sequencing studies is either case only or cases with relatively few controls, resulting in potential loss of statistical power for discovery of disease associated genes. Here we show that for a given number of sequenced cases, a large control sample size is critical to maximize power for rare variant burden analysis. Furthermore, we have developed an end-to-end workflow based tool (CoCoRV-nf) to facilitate the use of external biobank sequence resources as controls. The modules include consistent variant QC, variant annotation, ancestry population prediction, and gene based burden analysis using summary genotype information, and combined analysis from multiple independent results. The tool supports exomes and genomes from gnomAD and All of Us as controls with preprocessed datasets. We apply the tool in two rare neurological diseases: amyotrophic lateral sclerosis and neuroblastoma. For each disease, two case cohorts are paired with gnomAD and All of Us data, respectively, followed by a combined analysis. Not only did we recapture known genes, but also, we identified new candidate genes for both diseases. By leveraging multiple large external biobank sequence data, we demonstrate the feasibility of using our tool to maximize statistical power to identify new disease predisposition genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseAmyotrophic Lateral SclerosisNeuroblastomaSoftwareHumansBiological Specimen BanksCost-Benefit AnalysisGenetic VariationGenetic Association Studies

Stichwörter der Autor:innen

biobank sequence resourcesexternal controlspredisposition genesrare variant burden analysis

Autor:innen und Institutionen

  • Department of Cell & Molecular Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Sheffield Institute for Translational Neuroscience, University of Sheffield, Western Bank Sheffield S10 2TN, United Kingdom.
  • Department of Neurology and ALS Center, University of Miami Miller School of Medicine, 1600 NW 10th Avenue, Miami, FL 33136, United States.
  • Center for Applied Bioinformatics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester 55905, United States.

ORCID-Profile: Michael Benatar, Gang Wu, Wenan Chen

Förderung

  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Tithi, S. S., Cooper-Knock, J., Benatar, M., Wuu, J., Taylor, J. P., Wu, G., & Chen, W. (2026). CoCoRV-nf: a powerful and cost-effective tool for rare variant analysis leveraging external biobank sequence data identified new candidate predisposition genes in amyotrophic lateral sclerosis and neuroblastoma. Human Molecular Genetics, 35(17). https://doi.org/10.1093/hmg/ddag076

Vancouver

Tithi SS, Cooper-Knock J, Benatar M, Wuu J, Taylor JP, Wu G, et al. CoCoRV-nf: a powerful and cost-effective tool for rare variant analysis leveraging external biobank sequence data identified new candidate predisposition genes in amyotrophic lateral sclerosis and neuroblastoma. Human Molecular Genetics. 2026;35(17). doi:10.1093/hmg/ddag076

BibTeX
@article{Tithi2026,
  author = {Tithi, Saima Sultana and Cooper-Knock, Johnathan and Benatar, Michael and Wuu, Joanne and Taylor, J Paul and Wu, Gang and Chen, Wenan},
  title = {CoCoRV-nf: a powerful and cost-effective tool for rare variant analysis leveraging external biobank sequence data identified new candidate predisposition genes in amyotrophic lateral sclerosis and neuroblastoma},
  journal = {Human Molecular Genetics},
  year = {2026},
  volume = {35},
  number = {17},
  doi = {10.1093/hmg/ddag076}
}
Kostenlos starten →